7.38 USD
↘ 0.89 (10.76%)AT CLOSE (11:59 AM EDT)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
7.37
↘ 0.01 (0.14%)
POST MARKET (AS OF 07:39 PM EDT)
Post Market
AS OF 07:39 PM EDT
7.37
↘ 0.01 (0.14%)
Market: CLOSED
Open?$8.21
High?$8.21
Low?$7.33
Prev. Close?$8.27
Volume?120.3K
Avg. Volume?180.2K
VWAP?$7.64
Rel. Volume?0.67x
Bid / Ask
Bid?$6.25 × 100
Ask?$8.46 × 100
Spread?$2.21
Midpoint?$7.36
Valuation & Ratios
Market Cap?216.8M
Shares Out?29.4M
Float?10.2M
Float %?39.4%
P/E Ratio?N/A
P/B Ratio?-1.46
EPS?-$5.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
216.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.65Strong
Quick Ratio?7.65Strong
Cash Ratio?7.44Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?-1.46CHEAP▾
P/S?122.16HIGH▾
P/FCF?N/A▾
EV/EBITDA?-1.1CHEAP▾
EV/Sales?55.32HIGH▾
Returns & Efficiency
ROE?104.2%STRONG▾
ROA?-53.5%WEAK▾
Cash Flow & Enterprise
FCF?$-77374000
Enterprise Value?$98.2M
Fundamentals ratios updated end of day